Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optima HealthFRA:J3N 22 Debt-to-EBITDA is 8.14 as of Mar. 2026, which is 42% above its 10-year median of 5.72. GuruFocus rates FRA:J3N with a GF Score™ of 22/100. The stock has 9 warning signs investors should review. Among 483 Healthcare Providers & Services companies, Optima Health ranks worse than 87.37% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Optima Health's Debt-to-EBITDA or its related term are showing as below:
FRA:J3N'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.59 Med: 5.72 Max: 19.56
Current: 8.2
During the past 5 years, the highest Debt-to-EBITDA Ratio of Optima Health was 19.56. The lowest was 1.59. And the median was 5.72.
FRA:J3N's Debt-to-EBITDA is ranked worse than 87.37% of 483
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs FRA:J3N: 8.20
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Optima Health Debt-to-EBITDA Related Terms
Optima Health Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Optima Health's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:J3N vs VEEV, BTSG, HQY: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, Optima Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optima Health Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optima Health's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Optima Health's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Optima Health (FRA:J3N) has a Debt-to-EBITDA of 8.14 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Optima Health. This is 42% above median its historical median of 5.72. Over the past decade, Optima Health's Debt-to-EBITDA has ranged from 1.59 to 19.56. According to the industry distribution chart, Optima Health ranks #422 out of 483 companies in the Healthcare Providers & Services industry, placing it in the top 87.4%.
Is Optima Health's Debt-to-EBITDA too high?
Optima Health's current Debt-to-EBITDA of 8.14 is 42% above median its 10-year median of 5.72. Over the past 10 years, this metric has ranged from a low of 1.59 to a high of 19.56. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Optima Health's value of 8.14 is 271.7% above this industry median. Based on the distribution chart, Optima Health ranks #422 out of 483 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Optima Health has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Optima Health's Debt-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Optima Health ranks #422 out of 483 companies for Debt-to-EBITDA. This places Optima Health in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Optima Health's value of 8.14 is 271.7% above this benchmark. Historically, Optima Health's own Debt-to-EBITDA has ranged from 1.59 to 19.56 over the past decade. While the company's 10-year median is 5.72 vs. the industry median of 2.19, Optima Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 483 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optima Health's current Debt-to-EBITDA of 8.14 is 271.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Optima Health. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optima Health's current Debt-to-EBITDA is 8.14, which is 42% above median its own 10-year median of 5.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optima Health stock overvalued right now?
Optima Health (FRA:J3N) has a current Debt-to-EBITDA of 8.14. The current Debt-to-EBITDA is 8.14, which is 42% above median its 10-year median of 5.72 and 271.7% above the Healthcare Providers & Services industry median of 2.19. Optima Health's overall GF Score™ is 22/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Optima Health (FRA:J3N), the current Debt-to-EBITDA is 8.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Optima Health PLC is a provider of technology-enabled corporate health and wellbeing solutions in the occupational health sector. The group offers a comprehensive range of flexible and progressive services, from statutory-driven workplace health surveillance medicals to proactive and preventive interventions, as well as workplace health advice and attendance management assessments. These services are ultimately rehabilitation programs and pathways designed to help people return to work.
22GF Score
Get the complete analysis for FRA:J3N
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:J3N has been successfully added to your 
